Fundz

Knight Therapeutics acquires Paladin Pharma business

Jun 17, 2025

Acquiring Company

Knight Therapeutics

Acquired Company

Paladin Pharma

MontrealMontrealHealth CareMedicalManufacturingBiotechnologyHealth CarePharmaceutical

Description

Knight Therapeutics Inc. has successfully completed the acquisition of Paladin Pharma Inc., following a cash payment of approximately $107 million. This strategic move aims to enhance Knight's business in Canada and Latin America. The acquisition is expected to integrate both organizations and significantly impact Knight's growth trajectory.

Quick answer

Knight Therapeutics is acquiring Paladin Pharma, announced June 17, 2025. Knight Therapeutics is based in Montreal, Quebec, Canada.

How much did Knight Therapeutics pay for Paladin Pharma?
The deal value was not disclosed.
What does Knight Therapeutics do?
Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and..
Where are Knight Therapeutics and Paladin Pharma based?
Knight Therapeutics is based in Montreal, Quebec, Canada. Paladin Pharma is based in Montreal, Quebec, Canada.
Who are the decision-makers at Knight Therapeutics?
Fundz holds 1 contact at Knight Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Knight Therapeutics, and when

When Knight Therapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Knight Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Knight Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Knight Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Knight Therapeutics

Location

Montreal, Quebec, Canada

About

Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Headquartered in Montreal, Knight has operations in Canada and in 10 countries in Latin America and has over 700 employees globally. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Knight Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Samira
Likely contact at this company
••••••••@••••••••

See Samira's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Knight Therapeutics's next move

Learn about Strategic plan

Frequently asked

Who acquired Paladin Pharma?

Paladin Pharma was acquired by Knight Therapeutics, based in Montreal. The deal was reported on June 17, 2025. Knight Therapeutics Inc. Knight Therapeutics is privately held and operates in Health Care.

When did Knight Therapeutics acquire Paladin Pharma?

Knight Therapeutics's acquisition of Paladin Pharma was reported on June 17, 2025. Knight Therapeutics Inc. has successfully completed the acquisition of Paladin Pharma Inc., following a cash payment of approximately $107 million. This strategic move aims to enhance Knight's business in Canada and Latin America. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Paladin Pharma do?

Paladin Pharma Inc. is a company involved in the pharmaceutical industry, focusing on the development and distribution of innovative medications and therapies. It is privately held, operating in Manufacturing, and is based in Montreal.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.